Plain-English translation of NCT03225144 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study run by the National Institute of Neurological Disorders and Stroke that aims to better understand rare progressive brain diseases like frontotemporal dementia and amyotrophic lateral sclerosis (ALS). Researchers will evaluate your condition through standard clinical tests and may collect blood, tissue, or spinal fluid samples to study how these diseases develop. The study also explores advanced brain imaging to identify markers that could help predict or monitor disease progression.
These are devastating neurodegenerative diseases that affect thinking, memory, and muscle strength, yet we don't fully understand why they happen or how they're connected. By studying patients and their genes, researchers hope to uncover shared biological pathways that could eventually lead to better treatments.
You likely qualify if…
You likely don't qualify if…
You will undergo clinical evaluations including tests to measure your thinking and movement abilities. Depending on which tests you agree to, you may donate blood samples, skin biopsies, or spinal fluid through a lumbar puncture, and you may have brain imaging scans. These research procedures help scientists collect biological material to study disease mechanisms in the laboratory. The study does not test a new medication but rather gathers information from carefully studied patients to advance our understanding of these conditions.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States